Meet Our Board of Directors
Our Board of Directors has each established their leadership in the industry. Raj Mehra, Ph.D. serves as CEO and President of Seelos. Dr. Mehra is joined by Richard W. Pascoe, who serves as Chairman of Seelos, as well as a strategic advisor and a member of the board of directors of PriZm Therapeutics, an ultra-rare disease company; Margaret Dalesandro, PhD, Founder and President, Brecon Pharma Consulting LLC.; and Brian Lian, Ph.D., CEO and President of Viking Therapeutics, Inc. Each assist Seelos management in our strategic planning and ensures sound decision-making regarding our goals for the short- and long-term. They review, understand, and help ensure that Seelos has the right plans, the right people, and an optimized pipeline to help us progress towards the achievement of our objectives and to build shareholder value.
| Raj Mehra, PhD | Founder and Chief Executive Officer, Seelos Therapeutics, Inc. |
| Richard Pascoe | Chairman, Seelos Therapeutics, Inc., and strategic advisor and member of the board of directors of PriZm Therapeutics |
| Margaret Dalesandro, PhD | Founder and President, Brecon Pharma Consulting, LLC |
| Brian Lian, PhD | CEO and President, Viking Therapeutics, Inc. |